enCore Energy Corp. (CVE:EU - Get Free Report) shares fell 20.9% during trading on Thursday . The company traded as low as C$2.86 and last traded at C$2.95. 510,605 shares traded hands during trading, an increase of 56% from the average session volume of 327,150 shares. The stock had previously closed at C$3.73.
enCore Energy Stock Up 1.9%
The firm has a market cap of C$431.04 million, a price-to-earnings ratio of -7.65 and a beta of 1.20. The stock's 50-day moving average price is C$3.70 and its 200 day moving average price is C$2.94.
enCore Energy Company Profile
(
Get Free Report)
enCore Energy Corp. engages in the acquisition, exploration, and development of uranium resource properties in the United States. It holds a 100% interest in the Crownpoint and Hosta Butte uranium project that covers 3,020 acres located in the Grants Uranium Belt, New Mexico. The company also has interests in the Marquez-Juan Tafoya property, which consists of 14,582 acres located in McKinley and Sandoval counties of New Mexico; and the Nose Rock project that covers 42 owned unpatented lode mining claims comprising approximately 800 acres located in McKinley County, New Mexico.
Recommended Stories
Before you consider enCore Energy, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and enCore Energy wasn't on the list.
While enCore Energy currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.